Key result
Targeting metabolism via CPT1 inhibition shows potential for post-injury cardiac regeneration but lacks clinical data.
Why the study?
Heart failure is a leading cause of death due to the adult mammalian heart's inability to regenerate after injury, making novel regenerative approaches crucial.
Understanding the mechanisms that regulate cardiac metabolism is key to unlocking metabolic interventions for heart failure and promoting adult heart regeneration.
Answers are grounded in this paper and cite their sources.
Metabolic targeting for regeneration requires clinical validation; leaves open its role in human heart failure pending dedicated trials.
Heart failure is the leading cause of death worldwide. The inability of the adult mammalian heart to regenerate following injury results in the development of systolic heart failure. Thus, identifying novel approaches toward regenerating the adult heart has enormous therapeutic potential for adult heart failure. Mitochondrial metabolism is an essential homeostatic process for maintaining growth and survival. The emerging role of mitochondrial metabolism in controlling cell fate and function is beginning to be appreciated. Recent evidence suggests that metabolism controls biological processes including cell proliferation and differentiation, which has profound implications during development and regeneration. The regenerative potential of the mammalian heart is lost by the first week of postnatal development when cardiomyocytes exit the cell cycle and become terminally differentiated. This inability to regenerate following injury is correlated with the metabolic shift from glycolysis to fatty acid oxidation that occurs during heart maturation in the postnatal heart. Thus, understanding the mechanisms that regulate cardiac metabolism is key to unlocking metabolic interventions during development, disease, and regeneration. In this review, we will focus on the emerging role of metabolism in cardiac development and regeneration and discuss the potential of targeting metabolism for treatment of heart failure.
No takes yet. Share an insight, caveat, or question.
Bae et al. (2021) conducted a review in Heart failure and regeneration. null vs. null was evaluated on Promotion of heart regeneration via targeted metabolism (null, 95% CI null, p=null). Targeting metabolism, such as through CPT1 inhibition, shows potential for improving cardiac regeneration following injury, but current evidence from animal studies lacks strong clinical trial data with specific metrics.
Synapse has enriched 10 related papers. Consider them for comparative context: